Addiction News and Research

RSS

U.S. ban on menthol cigarettes will lead more than 1.3 million smokers to quit

A new study projects that a U.S. ban on menthol cigarettes, proposed by the U.S. Food and Drug Administration, will lead more than 1.3 million smokers to quit. Among them, Black smokers will see the greatest impact.

28 Apr 2022

MAPK pathway mutations can provide “precision” treatment targets for head and neck cancer

About one-fifth of often deadly head and neck cancers harbor genetic mutations in a pathway that is key to normal cell growth, and scientists report those mutations, which enable abnormal cancer cell growth, can also make the cancer vulnerable.

28 Apr 2022

Researchers unravel why neuropsychiatric symptoms appear in Alzheimer's patients before memory loss

Researchers from Indiana University School of Medicine are studying why neuropsychiatric symptoms, such as apathy and irritability, appear in most Alzheimer's disease patients before the onset of memory loss.

28 Apr 2022

Analysis finds reductions in cigarette use among people with major depression, substance use disorder

Significant reductions in cigarette use were found among U.S. adults with major depression, substance use disorder, or both from 2006 to 2019, according to a new analysis of nationally representative survey data published today in JAMA.

26 Apr 2022

Disasters can disrupt access to medications for opioid use disorder in vulnerable communities

The COVID-19 pandemic has spiked the overdose death rate from opioid use. For people who rely on medications (buprenorphine, methadone, and extended-release naltrexone) to treat opioid use disorders, the pandemic and such natural disasters as tornados, hurricanes, and wildfires can disrupt access to medications.

20 Apr 2022

UK experts share their work in the field of opioid use disorder research at 2022 Rx Summit

University of Kentucky experts on the front lines of the nation's opioid and addiction crises will share their work in the field of opioid use disorder research, treatment and prevention this week at the 2022 Rx Drug Abuse & Heroin Summit in Atlanta April 18-22.

19 Apr 2022

Pod-based e-cigarette use alters the inflammatory state across multiple organ systems

Researchers at University of California San Diego School of Medicine report that daily use of pod-based e-cigarettes alters the inflammatory state across multiple organ systems including the brain, heart, lungs and colon. Effects also vary depending on the e-cigarette flavor, and can influence how organs respond to infections, such as SARS-CoV-2.

13 Apr 2022

Magic mushroom compound helps to 'open up' depressed people's brains after use

Psilocybin, the psychedelic compound found in magic mushrooms, helps to "open up" depressed people's brains, even after use, enabling brain regions to talk more freely to one another.

11 Apr 2022

Hyperbaric oxygen therapy may help people in opioid addiction treatment

Hyperbaric oxygen therapy may help people being treated for opioid addiction reduce their methadone dose and better manage pain and withdrawal symptoms, according to a pair of studies led by Washington State University scientists.

11 Apr 2022

Smoking cessation could help heart disease patients gain five years of healthy life

Smoking cessation adds the same number of heart disease-free years to life as three preventive medications combined, according to research presented at ESC Preventive Cardiology 2022, a scientific congress of the European Society of Cardiology.

7 Apr 2022

Never-ending costs: When resolved medical bills keep popping up

Every now and then, Suzanne Rybak and her husband, Jim, receive pieces of mail addressed to their deceased son, Jameson. Typically, it's junk mail that requires little thought, Suzanne said.

7 Apr 2022

$11M for North Carolina work-based rehab raises concerns

An addiction treatment facility, highly regarded by North Carolina lawmakers, sits in a residential neighborhood here and operates like a village in itself.

6 Apr 2022

CBD and THC may be safe for use with opioid pain relievers, animal study suggests

Findings from a new animal study suggest that cannabidiol (CBD) and tetrahydrocannabinol (THC) might be safe for use with opioid pain relievers.

4 Apr 2022

Adolescents with higher drug use severity do not transition out of symptomatic substance use

People who reported multiple symptoms consistent with severe substance use disorder at age 18 exhibited two or more of these symptoms in adulthood, according to a new analysis of a nationwide survey in the United States.

1 Apr 2022

Study shows clinical value of pharmacogenomic testing for patients with treatment-resistant depression

Pharmacogenetic testing was associated with nearly a two-fold (89 per cent) increase in remission rates compared to treatment as usual in a Centre for Addiction and Mental Health- (CAMH-)led clinical study just published in the journal Translational Psychiatry.

29 Mar 2022

FDA requests nearly 34% increase in funding as part of the President’s fiscal year 2023 budget

Today, the U.S. Food and Drug Administration announced it is requesting a total budget of $8.4 billion as part of the President's fiscal year (FY) 2023 budget - a nearly 34% ($2.1 billion) increase over the agency's FY 2022 appropriated funding level for investments in critical public health modernization, core food safety and medical product safety programs and other vital public health infrastructure.

29 Mar 2022

At a Tennessee crossroads, two pharmacies, a monkey, and millions of pills

It was about 1 a.m. on April 19, 2016, when a burglary alarm sounded at Dale Hollow Pharmacy in Celina, a tiny town in the rolling, wooded hills near the Kentucky border.

29 Mar 2022

Tablet containing cannabidiol effectively reduces pain after shoulder surgery

An orally absorbed tablet containing cannabidiol (CBD) effectively reduces pain after shoulder surgery with no safety concerns, a new study finds.

25 Mar 2022

A psychedelic drug plus psychotherapy could help improve PTSD symptoms

Post-traumatic stress disorder (PTSD) affects millions of people each year, mostly survivors and witnesses of terrifying or shocking events, such as warfare, assaults or disasters. Because existing treatments don't work for everyone, new therapies are urgently needed.

22 Mar 2022

Most individuals treated in emergency departments for opioid use disorder do not sustain treatment

Most people who fill prescriptions from emergency physicians to treat their opioid use disorder do not continue to receive the medication, suggesting new approaches are needed to help people continue drug treatment begun on an emergency basis, according to a new RAND Corporation study.

21 Mar 2022

Addiction News and Research

U.S. ban on menthol cigarettes will lead more than 1.3 million smokers to quit

MAPK pathway mutations can provide “precision” treatment targets for head and neck cancer

Researchers unravel why neuropsychiatric symptoms appear in Alzheimer's patients before memory loss

Analysis finds reductions in cigarette use among people with major depression, substance use disorder

Disasters can disrupt access to medications for opioid use disorder in vulnerable communities

UK experts share their work in the field of opioid use disorder research at 2022 Rx Summit

Pod-based e-cigarette use alters the inflammatory state across multiple organ systems

Magic mushroom compound helps to 'open up' depressed people's brains after use

Hyperbaric oxygen therapy may help people in opioid addiction treatment

Smoking cessation could help heart disease patients gain five years of healthy life

Never-ending costs: When resolved medical bills keep popping up

$11M for North Carolina work-based rehab raises concerns

CBD and THC may be safe for use with opioid pain relievers, animal study suggests

Adolescents with higher drug use severity do not transition out of symptomatic substance use

Study shows clinical value of pharmacogenomic testing for patients with treatment-resistant depression

FDA requests nearly 34% increase in funding as part of the President’s fiscal year 2023 budget

At a Tennessee crossroads, two pharmacies, a monkey, and millions of pills

Tablet containing cannabidiol effectively reduces pain after shoulder surgery

A psychedelic drug plus psychotherapy could help improve PTSD symptoms

Most individuals treated in emergency departments for opioid use disorder do not sustain treatment

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News